Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5397
-0.0556 %
$ 23 M
Market Cap
-3.17
P/E
ADAP - FREE CASH FLOW
Free Cash Flow ADAP - Adaptimmune Therapeutics plc
-146 M
LAST VALUE
-770.78%
2 YEAR CAGR
-5.97%
5 YEAR CAGR
-33.80%
10 YEAR CAGR